Published in Diabet Med on December 10, 1987
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med (1984) 1.90
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol (1998) 1.40
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology (1998) 1.34
Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci U S A (1998) 1.34
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
Interaction of rheumatoid factor with infectious herpes simplex virus-antibody complexes. Science (1971) 1.20
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) (2006) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Proteinuria in diabetes. Diabetologia (1983) 1.07
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes (2000) 1.07
Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 1.04
Microalbuminuria as prediction of nephropathy in diabetics. Lancet (1982) 1.02
Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia (1995) 1.00
Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord (2000) 0.98
Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care (2000) 0.97
Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes (2000) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Dietary composition and renal function in healthy subjects. Nephron (1987) 0.94
Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) (1981) 0.93
Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci Lett (2000) 0.92
Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int (1994) 0.92
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. Diabetes Care (2000) 0.91
Diabetic nephropathy. Br Med Bull (1989) 0.91
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes (1996) 0.91
Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med (1983) 0.87
The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron (2002) 0.87
Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant (1999) 0.87
Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharmacol (1999) 0.86
Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol (Oxf) (1984) 0.86
Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia (2008) 0.86
Early functional and morphological changes in diabetic nephropathy. Clin Nephrol (1979) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron (1984) 0.84
P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia (2003) 0.84
Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant (1997) 0.84
Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia (1993) 0.84
Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care (1987) 0.84
Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration. Diabetes (1982) 0.83
Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes (1988) 0.83
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. Metabolism (1980) 0.82
Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia (1996) 0.81
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes (2000) 0.81
Changes in renal function in response to protein restricted diet in type 1 (insulin-dependent) diabetic patients. Diabetologia (1987) 0.81
Glucose-induced hyperkalaemia: A hazard for diabetics? Lancet (1978) 0.81
Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation. Shock (2000) 0.81
Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J (Clin Res Ed) (1986) 0.80
Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1981) 0.80
High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia (1997) 0.80
Immunopathology and immunoprotection in CNS virus infections: mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol (2002) 0.80
Dietary protein and the diabetic kidney. Diabet Med (1987) 0.80
N-methyl-D-aspartate receptor-mediated events contribute to neurovascular breakdown during experimental allergic encephalomyelitis. Biochem Soc Trans (1997) 0.78
Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. J Lab Clin Med (1993) 0.78
Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa. Horm Metab Res (1976) 0.78
ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev (1999) 0.78
Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. Eur J Pharmacol (1998) 0.78
Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia (1980) 0.78
LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia (1994) 0.78
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255. Diabetes (2007) 0.78
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine. Acta Endocrinol (Copenh) (1977) 0.78
Subcellular distribution of intravenously injected 125I-labelled insulin in rat liver. Int J Biochem (1981) 0.77
Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med (1994) 0.77
An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic. Diabet Med (2001) 0.77
Premature cell ageing and evolution of diabetic nephropathy. Diabetologia (1997) 0.77
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. Metabolism (1980) 0.77
Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease. Kidney Int Suppl (2005) 0.77
Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake. Nephron (1997) 0.76
Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med (1991) 0.76
Misleading meta-analysis: a need to look beyond the headlines. Diabet Med (2007) 0.76
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion. Diabetologia (1993) 0.76